HK1168596A1 - Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds 2-(1-)-1- - Google Patents

Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds 2-(1-)-1-

Info

Publication number
HK1168596A1
HK1168596A1 HK12109356.5A HK12109356A HK1168596A1 HK 1168596 A1 HK1168596 A1 HK 1168596A1 HK 12109356 A HK12109356 A HK 12109356A HK 1168596 A1 HK1168596 A1 HK 1168596A1
Authority
HK
Hong Kong
Prior art keywords
isoindolin
phenylethyl
compounds
processes
preparation
Prior art date
Application number
HK12109356.5A
Other languages
English (en)
Chinese (zh)
Inventor
Anthony J Frank
Hon-Wah Man
Chuangseng Ge
Manohar Saindaine
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of HK1168596A1 publication Critical patent/HK1168596A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK12109356.5A 2009-10-09 2012-09-21 Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds 2-(1-)-1- HK1168596A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25042109P 2009-10-09 2009-10-09
PCT/US2010/052005 WO2011044479A1 (en) 2009-10-09 2010-10-08 Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds

Publications (1)

Publication Number Publication Date
HK1168596A1 true HK1168596A1 (en) 2013-01-04

Family

ID=43301314

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109356.5A HK1168596A1 (en) 2009-10-09 2012-09-21 Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds 2-(1-)-1-

Country Status (21)

Country Link
US (1) US8415485B2 (de)
EP (1) EP2486012B1 (de)
JP (1) JP5753177B2 (de)
KR (1) KR20120084306A (de)
CN (1) CN102639498A (de)
AR (1) AR078581A1 (de)
AU (1) AU2010303243B2 (de)
BR (1) BR112012007737A2 (de)
CA (1) CA2775581A1 (de)
CR (1) CR20120169A (de)
EC (1) ECSP12011781A (de)
ES (1) ES2451350T3 (de)
HK (1) HK1168596A1 (de)
IL (1) IL218898A0 (de)
MX (1) MX2012004024A (de)
MY (1) MY183201A (de)
NI (1) NI201200049A (de)
NZ (1) NZ599147A (de)
RU (1) RU2557236C2 (de)
WO (1) WO2011044479A1 (de)
ZA (1) ZA201202380B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
WO2014204825A1 (en) 2013-06-17 2014-12-24 Celgene Corporation Tablet formulations of (+)-2-[1 -(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CN104447443B (zh) * 2014-12-05 2016-07-27 新发药业有限公司 一种阿普斯特及其中间体的制备方法
CN115850129B (zh) * 2023-02-28 2023-05-16 凯莱英生命科学技术(天津)有限公司 （s）-1-(3-乙氧基-4-甲氧基苯基)-2-（甲磺酰基）乙胺的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them
US5703098A (en) * 1994-12-30 1997-12-30 Celgene Corporation Immunotherapeutic imides/amides
US6020358A (en) 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US20100129363A1 (en) 2002-05-17 2010-05-27 Zeldis Jerome B Methods and compositions using pde4 inhibitors for the treatment and management of cancers
CN1802353A (zh) 2002-12-30 2006-07-12 细胞基因公司 氟烷氧基取代的1,3－二氢－异吲哚化合物及其药物用途
US7034052B2 (en) * 2003-03-12 2006-04-25 Celgene Corporation 7-Amido-isoindolyl compounds and their pharmaceutical uses
CH696542A5 (de) * 2003-07-09 2007-07-31 Siegfried Ltd Verfahren zur Herstellung von substituierten 2,6-Dioxopiperidin-3-yl-Verbindungen.
ES2299906T3 (es) * 2003-11-25 2008-06-01 Eli Lilly And Company Moduladores de receptores activados por proliferadores de peroxisomas.
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
US7142423B2 (en) * 2004-10-26 2006-11-28 Comarco Wireless Technologies, Inc. Power adapter with fan assembly
CN101309905A (zh) * 2005-08-12 2008-11-19 阿斯利康(瑞典)有限公司 取代的异吲哚酮及其作为代谢型谷氨酸受体增效剂的用途
TW200804281A (en) * 2006-02-16 2008-01-16 Astrazeneca Ab New metabotropic glutamate receptor-potentiating isoindolones
CA2700841A1 (en) * 2007-09-27 2009-04-02 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
WO2009120296A1 (en) * 2008-03-24 2009-10-01 Celgene Corporation Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide

Also Published As

Publication number Publication date
WO2011044479A1 (en) 2011-04-14
EP2486012B1 (de) 2013-12-11
IL218898A0 (en) 2012-06-28
CR20120169A (es) 2012-07-30
RU2012118615A (ru) 2013-11-20
ZA201202380B (en) 2013-06-26
US8415485B2 (en) 2013-04-09
BR112012007737A2 (pt) 2015-09-15
ECSP12011781A (es) 2012-07-31
NI201200049A (es) 2012-11-27
NZ599147A (en) 2014-03-28
AR078581A1 (es) 2011-11-16
KR20120084306A (ko) 2012-07-27
US20110087033A1 (en) 2011-04-14
MX2012004024A (es) 2012-05-08
ES2451350T3 (es) 2014-03-26
JP5753177B2 (ja) 2015-07-22
AU2010303243A1 (en) 2012-05-03
CN102639498A (zh) 2012-08-15
RU2557236C2 (ru) 2015-07-20
CA2775581A1 (en) 2011-04-14
MY183201A (en) 2021-02-18
JP2013507389A (ja) 2013-03-04
AU2010303243B2 (en) 2014-08-28
EP2486012A1 (de) 2012-08-15

Similar Documents

Publication Publication Date Title
PL2604268T3 (pl) Sposób wytwarzania pochodnych tiazolu
ZA201202504B (en) Process for the preparation of calcobutrol
SI2387566T1 (sl) Postopek za pripravo rosuvastatina
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
ZA201202343B (en) Process for the preparation of lenalidomide
ZA201205192B (en) Process for the preparation of chelated compounds
IL214906A (en) A process for making Iwan
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
ZA201207397B (en) Process for the preparation of dexlansoprazole
HK1168596A1 (en) Processes for the preparation of 2-(1-phenylethyl) isoindolin-1-one compounds 2-(1-)-1-
IL221184A (en) A process for preparing 1-alkylated tetrazole 5 is produced
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
PL2391352T3 (pl) Formy farmaceutyczne stosowane do uwalniania związków aktywnych
EP2499125A4 (de) Verfahren zur racematspaltung von omeprazol
IL215022A0 (en) Novel process for the preparation of enaminocarbonyl compounds
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
SI2387557T1 (sl) Postopek za pripravo N-(5-(3-dimetilamino-akriloil)-2-fluorofenil)-N-metil-acetamida
GB0904311D0 (en) Processes for the preparation of compounds
IL220160A (en) A process for the preparation of defrasirox
PL389981A1 (pl) Sposób otrzymywania związków fosforoorganicznych
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
PL392605A1 (pl) Sposób otrzymywania 2-(2-hydroksypropyl)oksykarbonylo-5-norbornenu
PL388528A1 (pl) Sposób otrzymywania aldoli tropinonu

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171008